Skip to main content
Premium Trial:

Request an Annual Quote

Merck Licenses Spotfire's Lead Discovery Software

Premium

CAMBRIDGE, Mass.--Spotfire announced that Merck has licensed its new-leads discovery system for distribution worldwide across all Merck research sites. The system, which features Spotfire Pro and Spotfire Structure Visualizer, will help Merck biologists and chemists engaged in drug discovery to identify promising drug candidates by enabling them to access and analyze information about relationships between chemical structure and biological activity.

Filed under

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.